VIVIMED LABS LIMITED ,HYDERABAD vs. ACIT, CENTRAL CIRCLE-8(1), HYDERABAD
In the result, appeal filed by the assessee is partly allowed for statistical purposes
ITA 428/HYD/2022[2018-19]Status: DisposedITAT Hyderabad30 Jan 2023AY 2018-19
Bench: Shri R.K. Panda & Shri Laliet Kumarassessment Year: 2018-19 M/S. Vivimed Labs Ltd Vs. A.C.I.T. Hyderabad Central Circle 8(1) Pan:Aaacv6060A Hyderabad (Appellant) (Respondent) Assessee By: Shri P. Murali Mohan Rao, Ca Revenue By: Smt. K. Haritha, Dr Date Of Hearing: 18/01/2023 Date Of Pronouncement: 30/01/2023 Order Per R.K. Panda, A.M This Appeal Filed By The Assessee Is Directed Against The Order Dated 30.07.2022 Passed By The Assessing Officer U/S 143(3) R.W.S. 144C(13) Of The I.T. Act Relating To A.Y.2018-19. 2. Facts Of The Case, In Brief, Are That The Assessee Is A Company Engaged In The Business Of Manufacturing Of Specialties & Medicines. It Filed Its Return Of Income For The Impugned A.Y On 31.3.2019 Admitting Total Income Of Rs.17,04,19,502/- Under The Normal Provisions Of The I.T. Act & Book Profit Of Rs.8,85,19,711/- Under Mat Provisions. The Case Of The Assessee Was Selected For Scrutiny Under Cass. Accordingly Statutory Notices U/S 143(2) & 142(1) Were Issued & Served On The Page 1 Of 17
For Appellant: Shri P. Murali Mohan Rao, CAFor Respondent: Smt. K. Haritha, DR
Section 1Section 143(2)Section 143(3)Section 14ASection 92BSection 92B(1)Section 92C
disallowance u/s 14A and the addition of Rs.67,46,635/- being duty drawback received. The Assessing
Page 2 of 17
ITA No 428 of 2022 Vivimed Labs Ltd Hyderabad
Officer in the final order passed on 30.07.2022 made the above additions as sustained by the DRP and determined the total income at Rs.20,50,33,895/-.
6. Aggrieved with such